FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

OLEMA PHARMACEUTICALS, INC.: cashflow_investing

One fact, its scope and the complete path back to the official record.

Period: 2022-01-01 – 2022-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/7ce81be3-d92c-46bf-bc99-e2fad1e952f4

Reported value

$91.479M{"amount": 91479000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Entity
OLEMA PHARMACEUTICALS, INC.
Metric
cashflow_investing
Period
2022-01-01 – 2022-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001558370-23-003318 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T17:49:54.508708+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001750284/cashflow-investing/2022-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.